Trial Details

Authorised
Basic Information
Clinical ID c5118
Identifier EUCTR2011-001332-29-AT
Trial Title Pharmacokinetics of Infliximab
Trial URL Visit Original Page
Study Information
Study Results

NULL
Conditions Inflammatory bowel disease (Ulcerative Colitis, Crohn's disease) MedDRA version: 17.0.Level: PT.Classification code 10011401.Term: Crohn's disease.System Organ Class: 10017947 - Gastrointestinal disorders. M
Interventions Trade Name: RemicadeProduct Name: RemicadePharmaceutical Form: Powder for solution for injection/infusionINN or Proposed INN: INFLIXIMABCAS Number: 170277-31-3Other descriptive name: RemicadeConcentration unit: mg/ml milligram(
Participant Information
Sponsor Universitsklinik f Innere Medizin III, Klinische Abteilung f Gastroenterologie und Hepatologie
City NULL
Country/Region Austria
Enrollment Criteria
Sex Requirement NOT SPECIFIED
Age Requirement NULL
Study Design
Study Type Interventional clinical trial of medicinal product
Phase NULL
Time Information
Start Date NULL
Primary Completion Date NULL
Completion Date NULL